Abstract
Drug-metabolizing enzymes were investigated in duodenal biopsy specimens. Cytochrome P4501A (CYP1A) activity was determined by measuring 7-ethoxyresorufin O-deethylase (EROD) activity in biopsies from 20 smokers (3–30 cigarettes per day), 21 nonsmokers, and 10 nonsmokers receiving omeprazole treatment (20–60 mg/day for at least 1 week). Omeprazole is known to act as a polycyclic aromatic hydrocarbon (PAH)-type inducer in humans.
EROD activity was found to be significantly induced in smokers and omeprazole-treated patients, with medians of 2.1 and 1.1 pmol· min−1·mg protein−1, respectively, compared with 0.5 pmol·min−1·mg protein−1 in nonsmokers. Immunoblot analysis substantiated that EROD activity was correlated with CYP1A protein. In contrast, UDP-glucuronosyltransferase (UGT) activity towards 4-methylumbelliferone (an overlapping substrate of several constitutive and inducible UGTs) was not significantly affected.
The results demonstrate CYP1A induction by omeprazole and by constituents of cigarette smoke in the human duodenum and support the utility of duodenal biopsies to monitor CYP1A induction by PAH-type inducers.
Similar content being viewed by others
References
Wattenberg LW, Leong JL, Strand PJ (1962) Benzpyrene hydroxylase activity in the gastrointestinal tract. Cancer Res 22:1120–1125
Hoensch HP, Hutt R, Hartmann F (1979) Biotransformation of xenobiotics in human intestinal mucosa. Environ Health Perspect 33:71–78
Hoensch HP, Steinhardt HJ, Weiss G, Haug D, Maier A, Malchow H (1984) Effects of semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small intestinal mucosa in humans. Gastroenterology 86:1519–1530
Pacifici GM, Franchi M, Bencini C, Repetti F, Di Lascio N, Muraro GB (1988) Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica 18:849–856
Peters WHM, Kremers PG (1989) Cytochromes P-450 in the intestinal mucosa of man. Biochem Pharmacol 38:1535–1538
Peters WHM, Nagengast FM, Tongeren JHM van (1989) Glutathione S-transferase, cytochrome P450, and uridine 5'diphosphate-glucuronosyltransferase in human small intestine and liver. Gastroenterology 96:783–789
Waziers I de, Cugnenc H, Yang CS, Leroux J-P, Beaune PH (1990) Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253:387–394
Kaminsky LS, Fasco M (1992) Small intestinal cytochromes P450. CRC Rev Toxicol 21:407–422
Hartmann F, Bissell DM (1982) Metabolism of heme and bilirubin in rat and human small intestinal mucosa. J Clin Invest 70:23–27
Watkins PB, Wrighton SA, Schuetz EG, Molowa DT, Guzelian PS (1987) Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Invest 80:1029–1036
Conney AH (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes memorial lecture. Cancer Res 42:4875–4917
Pelkonen O, Pasanen M, Kuha H, Gachalyi B, Kairaluoma M, Sotaniemi EA, Park SS, Friedman FK, Gelboin HV (1986) The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies. Br J Clin Pharmacol 22:125–134
Sesardic D, Boobis AR, Edwards RJ, Davies DS (1988) A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br J Clin Pharmacol 26:363–372
Poland A, Knutson JC (1982) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22:517–554
Whitlock JP (1990) Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol Toxicol 30:251–277
Bock KW (1994) Aryl hydrocarbon or dioxin receptor: biologic and toxic responses. In: Reviews of physiology, biochemistry and pharmacology, vol 125. Springer, Berlin Heidelberg New York, pp 1–42
Dolwick KM, Schmidt JV, Carver LA, Swanson HI, Bradfield CA (1993) Cloning and expression of a human Ah receptor cDNA. Mol Pharmacol 44:911–917
Hayashi S-I, Watanabe J, Nakachi K, Eguchi H, Gotoh O, Kawajiri K (1994) Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15:801–806
Wattenberg LW (1992) Inhibition of carcinogenesis by minor dietary constituents. Cancer Res [Suppl] 52:2085–2091
Diaz D, Fabre I, Daujat M, Saint Aubert B, Bories P, Michel H, Maurel P (1990) Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology 99:737–747
Quattrochi LC, Tukey RH (1993) Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene. Mol Pharmacol 43:504–508
McDonnell WM, Scheiman JM, Traber PG (1992) Induction of cytochrome P450IA genes (CYP1A) by omeprazole in the human alimentary tract. Gastroenterology 103:1509–1516
Jacobson M, Levin W, Poppers PJ, Wood AW, Conney AH (1974) Comparison of the O-dealkylation of 7-ethoxycoumarin and the hydroxylation of benzo[a]pyrene in human placenta. Clin Pharmacol Ther 16:701–710
Manchester DK, Jacoby EH (1981) Sensitivity of human placental monooxygenase activity to maternal smoking. Clin Pharmacol Ther 30:687–692
Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, McBride OW, Nebert DW (1991) Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 48:720–725
Kellermann G, Shaw CR, Luyten-Kellermann M (1973) Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N Engl J Med 289:934–937
Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP, McLemore TL (1982) Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res 42:5030–5037
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Burton, K (1956) A study on the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of DNA. Biochem J 62:315–323
Prough RA, Burke MD, Mayer RT (1978) Direct fluorometric methods for measuring mixed function oxidase activity. Methods Enzymol 52C:372–377
Pohl R, Fouts J (1980) A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal Biochem 107:150–155
Lilienblum W, Walli AK, Bock KW (1982) Differential induction of rat liver microsomal UDP-glucuronosyltransferase activities by various inducing agents. Biochem Pharmacol 31:907–913
Gautier JC, Urban P, Beaune P, Pompon D (1993) Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the two first steps of benzo(a)pyrene activation. Eur J Biochem 211:63–72
Buchmann A, Bock KW, Schwarz M (1992) Enzyme and immunohistochemical phenotyping of diethylnitrosamine-induced liver lesions of male C3H/He, B6C3F1 and C57BL/6J mice. Carcinogenesis 13:691–697
Bock KW, Schirmer G, Green MD, Tephly TR (1988) Properties of a 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase from rat liver. Biochem Pharmacol 37:1439–1443
Parkinson A, Hurwitz A (1991) Omeprazole and the induction of human cytochrome P-450: a response to concerns about potential adverse effects. Gastroenterology 100:1157–1164
Lucier GW, Thompson CL (1992) Omeprazole, cytochrome P450, and chemical carcinogenesis. Gastroenterology 102:1823–1824
Burchell B, Nebert DW, Nelson DR, Bock KW, Iyanagi T, Jansen PLM, Lancet D, Mulder GJ, Chowdhury JR, Siest G, Tephly TR, Mackenzie PI (1991) The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol 10:487–494
Ebner T, Remmel RP, Burchell B (1993) Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinyl estradiol. Mol Pharmacol 43:649–654
Bock KW, Forster A, Gschaidmeier H, Brück M, Münzel P, Schareck W, Fournel-Gigleux S, Burchell B (1993) Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem Pharmacol 45:1809–1814
Bock KW, Wiltfang J, Blume R, Ullrich D, Bircher J (1987) Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking. Eur J Clin Pharmacol 31:677–683
Bock KW, Schrenk D, Forster A, Griese E-U, Mörike K, Brockmeier D, Eichelbaum M (1994) The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferase in man using sparteine, caffeine and paracetamol as probes. Pharmacogenetics 4:209–218
Bock KW, Gschaidmeier H, Seidel A, Baird S, Burchell B (1992) Mono- and diglucuronide formation from chrysene and benzo(a)pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A1). Mol Pharmacol 42:613–618
Ouzzine M, Pillot T, Fournel-Gigleux S, Magdalou J, Burchell B, Siest G (1994) Expression and role of the human liver UDP-glucuronosyltransferase UGT1*6 analyzed by specific antibodies raised against a hybrid protein produced in Escherichia coli. Arch Biochem Biophys 310:196–204
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buchthal, J., Buchmann, A., Schrenk, D. et al. Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa. Eur J Clin Pharmacol 47, 431–435 (1995). https://doi.org/10.1007/BF00196857
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00196857